Zoledronic acid previously has been shown to prevent bone mineral density loss in prostate cancer patients just beginning hormone therapy.
患者开始进行激素治疗时使用唑来瞵酸能够保护骨密度降低的疗效，已被证实。
Zoledronic acid previously has been shown to prevent bone mineral density loss in prostate cancer patients just beginning hormone therapy.
患者开始进行激素治疗时使用唑来瞵酸能够保护骨密度降低的疗效，已被证实。
应用推荐